Gastrointestinal Complications After 3 Months of Dual Antiplatelet Therapy for Drug-eluting Stents as Assessed by Wireless Capsule Endoscopy

Abstract

Little is known about the frequency of symptomatic and asymptomatic gastrointestinal complications of dual antiplatelet therapy. We recruited 30 patients between 18 and 80 years who were started on aspirin and clopidogrel following percutaneous coronary intervention with drug-eluting stents. We hypothesized that the 3 months of dual antiplatelet therapy would be associated with frequent upper gastrointestinal endoscopic abnormalities. Patients were followed with weekly phone calls to inquire about the new gastrointestinal symptoms and after a minimum of 80 days, their upper gastrointestinal mucosa was visualized with PillCam ESO^® wireless capsule endoscopy. 18 (90%) of the 20 successful wireless capsule endoscopies revealed at least 1 type of gastrointestinal mucosal lesion. Gastric erosions (n = 14, 70%) were the most common abnormality. We believe this is the first noninvasive endoscopic study of gastrointestinal complications of dual antiplatelet therapy in patients who undergo percutaneous coronary intervention with drug-eluting stents. Future studies should expand on our observations to determine whether prophylaxis with proton pump inhibitors is warranted.

Keywords

aspirin clopedogel antiplatelent agents gastric erosions drug-eluting coronary stents

References

Patrono C. , Garcia Rodriguez LA , Landolfi R. , Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373-2383.

Antithrombotic Trialists ' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.

Mehta SR , Yusuf S. , Peters RJ , et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.

Yusuf S. , Zhao F. , Mehta SR , Chrolavicius S. , Tognoni G. , Fox KK Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.

Steinhubl SR , Berger PB , Mann JT 3rd , et al. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.

Eshaghian S. , Kaul S. , Amin S. , Shah PK , Diamond GA Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med. 2007 ;146:434-441.

Vane JR , Botting RM The mechanism of action of aspirin. Thromb Res. 2003;110:255-258.

Vane JR Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232-235.

Gachet C. , Stierle A. , Cazenave JP , et al. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man. Biochem Pharmacol . 1990;40:229-238.

10.

Mills DC , Puri R. , Hu CJ , et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb. 1992;12:430-436.

11.

Vallurupalli NG , Goldhaber SZ Gastrointestinal complications of dual antiplatelet therapy. Circulation. 2006;113:e655-e658.

12.

Weil J. , Colin-Jones D. , Langman M. , et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995;310:827-830.

13.

Grines CL , Bonow RO , Casey DE Jr , et al. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-818.

14.

Fork FT , Lafolie P. , Tóth E. , Lindgärde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scand J Gastroenterol . 2000;35:464-469.

15.

Ma L. , Elliott SN , Cirino G. , Buret A. , Ignarro LJ , Wallace JL Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A. 2001;98:6470-6475.

16.

Rosenstock SJ , Jorgensen T. Prevalence and incidence of peptic ulcer disease in a Danish County-a prospective cohort study. Gut. 1995;36:819-824.

17.

Yeomans ND , Lanas AI , Talley NJ , et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005;22:795-801.

18.

Chan FK , Ching JY , Hung LC , et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238-244.